VEANA THERAPEUTICS, INC.

Profile

Company Names

VEANA THERAPEUTICS, INC.

Addresses

9398 SW WASHINGTON STREET, PORTLAND, OR 97225

3720 SW BOND AVENUE, UNIT 508, PORTLAND, OR 97239

Phone Numbers

(503) 292-4065
5038690983

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, BIOTECHNOLOGY

Year Incorporated:

2015

State Incorporated:

DELAWARE

Total Amount Raised:

$1,372,998.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2020-10-21 
$830,998.00 
$1,265,000.00 
$434,002.00 
Equity 
1
2018-05-11 
$542,000.00 
$2,000,000.00 
$1,458,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
EMMANUEL 
 
AKPORIAYE 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
VEANA THERAPEUTICS, INC.
REBECCA 
 
AKPORIAYE 
EXECUTIVE OFFICER, DIRECTOR
VEANA THERAPEUTICS, INC.
DENIS 
R 
BURGER 
DIRECTOR
WHISPERING OAKS INTERNATIONAL INC   |  VEANA THERAPEUTICS, INC.
TRENT 
D 
DAVIS 
DIRECTOR
WHITESTONE INVESTMENT NETWORK, INC.   |  VEANA THERAPEUTICS, INC.
MARK 
F 
HOLIFER 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
VEANA THERAPEUTICS, INC.
THOMAS 
E 
MCCHESNEY 
EXECUTIVE OFFICER
CONNECTSOFT, INC.   |  WHITESTONE INVESTMENT NETWORK, INC.   |  SOCHULE, INC.   |  VEANA THERAPEUTICS, INC.
BRUCE 
 
RAMSEYER 
DIRECTOR
VEANA THERAPEUTICS, INC.
ANDREW 
 
RAY 
DIRECTOR
PIXELLIGENT TECHNOLOGIES LLC   |  VEANA THERAPEUTICS, INC.   |  SWARMIO MEDIA HOLDINGS INC.
F 
ANDREW 
RAY 
DIRECTOR
VEANA THERAPEUTICS, INC.
SANDRA 
 
SHOTWELL 
DIRECTOR
VEANA THERAPEUTICS, INC.   |  CYTOIMAGE INC.
ANDREW 
D 
THALER 
EXECUTIVE OFFICER
VEANA THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-11-13
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-10-21 
2018-05-21
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2018-05-11 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
NONE
NONE